How representative are clinical study patients with allergic rhinitis in primary care?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2010.10.058PMID 21269670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA2LEN Study

  2010cited by this paper
• Scottish Intercollegiate Guidelines Network

  2010cited by this paper
• What kind of randomised trials do patients and clinicians need?

  2009cited by this paper
• Guidelines for allergic rhinitis need to be used in primary care.

  2009cited by this paper
• Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study

  2009cited by this paper
• Is structured allergy history sufficient when assessing patients with asthma and rhinitis in general practice?

  2009cited by this paper
• Service evaluation of a UK primary care-based allergy clinic: quality improvement report.

  2009cited by this paper
• Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis.

  2009cited by this paper
• A new 'mechanistic-practical" framework for designing and interpreting randomized trials.

  2009cited by this paper
• Implementation of Guidelines for Allergic Rhinitis in Specialist Practices

  2009cited by this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cited by this paper
• General practitioners’ central role in management of asthma and allergic rhinitis

  2008cited by this paper
• Going from evidence to recommendations

  2008cited by this paper
• What is “quality of evidence” and why is it important to clinicians?

  2008cited by this paper
• Primary care: the cornerstone of diagnosis of allergic rhinitis

  2008cited by this paper
• The Brussels Declaration: the need for change in asthma management

  2008cited by this paper
• A 12‐week placebo‐controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis

  2008cited by this paper
• Original article: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines

  2007cited by this paper
• Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update

  2007cited by this paper
• Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

  2006cited by this paper
• Severity and impairment of allergic rhinitis in patients consulting in primary care.

  2006cited by this paper
• Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network *

  2005cited by this paper
• How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?

  2005cited by this paper
• Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine

  2005cited by this paper
• Management of allergic rhinitis in UK primary care: baseline audit.

  2005cited by this paper
• Prevalence and rate of diagnosis of allergic rhinitis in Europe

  2004cited by this paper
• Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.

  2004cited by this paper
• Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

  2003cited by this paper
• Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

  2003cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• On the need for evidence-based medicine.

  1995cited by this paper
• On the need for evidence-based medicine.

  1995cited by this paper
• Ten Tools of Continuous Quality Improvement: A Review and Case Example of Hospital Discharge

  1995cited by this paper
• Soluble markers of allergic inflammation

  1994cited by this paper

• Distinct treatment response trajectories to allergen immunotherapy in allergic asthma and rhinitis: Insights from a multicenter study in routine clinical practice

  2026cites this paper
• Concepts for the development of person-centred, digitally-enabled, Artificial Intelligence-assisted ARIA care pathways (ARIA 2024).

  2024cites this paper
• Predicting allergen immunotherapy efficacy based on early maintenance phase response in routine clinical practice

  2024cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach

  2023cites this paper
• Representativeness Of Rcts Participants On The Effect Of Cpap On Cardiovascular Outcomes: Caution Is Needed.

  2022cites this paper
• Infrastructure challenges to doing health research “where populations with the most disease live” in Covid times—a response to Rai et al. (2021)

  2022cites this paper
• Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey

  2021cites this paper
• Shifting research culture to address the mismatch between where trials recruit and where populations with the most disease live: a qualitative study

  2021cites this paper
• COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?

  2020cites this paper
• Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

  2020cites this paper
• Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?

  2020cites this paper
• Rhinitis 2020: A Practice Parameter Update.

  2020cites this paper
• Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD

  2020cites this paper
• Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics. A National Institute of Allergy and Infectious Diseases Workshop.

  2020cites this paper
• MP‐AzeFlu provides rapid and effective allergic rhinitis control: results of a non‐interventional study in Denmark

  2019cites this paper
• Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia

  2019cites this paper
• The "pragmatic trial": An essentially contested concept?

  2019cites this paper
• Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

  2019cites this paper
• 2. REAL WORLD EVIDENCE DATA IN AIT—WHAT DOES IT BRING TO US?

  2019cites this paper
• Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

  2019cites this paper
• Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study

  2018cites this paper
• MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.

  2018cites this paper
• 国际过敏与鼻科学共识声明 : 变应性鼻炎

  2018cites this paper
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

  2018cites this paper
• Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial

  2018cites this paper
• Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology

  2018influential citation
• Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?

  2017cites this paper
• Estimate of the total costs of allergic rhinitis in specialized care based on real‐world data: the FERIN Study

  2017cites this paper
• Unmet Primary Physicians' Needs for Allergic Rhinitis Care in Korea

  2017cites this paper
• A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu

  2017cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

  2017cites this paper
• Effect Antileukotriene Substances (Montelukast) In Patients With Changed Bronchial Reactivity (Non-Reactors, Moderate Reactors And Emphasized Reactors).

  2017cites this paper
• COMPARATIVE STUDY ON THE EFFICACY OF MOMETASONE AND FLUTICASONE NASAL SPRAYS FOR TREATMENT OF ALLERGIC RHINITIS

  2017cites this paper
• Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu

  2016cites this paper
• Efficacy of MP‐AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment

  2016influential citation
• ALLERGIC RHINITIS AND THE ENT PRACTICE

  2015cites this paper
• The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey

  2015cites this paper
• Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study

  2015cites this paper
• Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index

  2015cites this paper
• Current controversies and challenges in allergic rhinitis management

  2015cites this paper
• By the numbers: bringing new drugs for allergic/hypersensitivity diseases to the market.

  2015cites this paper
• Why most randomized controlled trials are irrelevant: And why yours will not be.

  2015cites this paper
• Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.

  2015cites this paper
• ALLERGIC RHINITIS AND THE ENT PRACTICE

  2015cites this paper
• Current controversies and challenges in allergic rhinitis

  2015cites this paper
• External Validity of Randomized Controlled Trials in Severe Asthma.

  2015cites this paper
• An observational, real‐life safety study of a 5‐grass pollen sublingual tablet in children and adolescents

  2014cites this paper
• Respiratory guidelines--which real world?

  2014cites this paper
• The influence of centre selection on the generalisability of economic evaluations conducted alongside randomised controlled trials : a case study from the Rossini trial

  2014cites this paper
• Integrating Evidence for Managing Asthma in Patients Who Smoke

  2014cites this paper
• Quality standards for real-world research. Focus on observational database studies of comparative effectiveness.

  2014cites this paper
• A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.

  2013cites this paper
• Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.

  2013cites this paper
• Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

  2013cites this paper
• Allergy management in primary care across European countries – actual status

  2013cites this paper
• Centre Selection for Clinical Trials and the Generalisability of Results: A Mixed Methods Study

  2013cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

  2012cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

  2012cites this paper
• A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.

  2012cites this paper
• Advances in upper airway diseases and allergen immunotherapy in 2011.

  2012cites this paper
• Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care

  2012cites this paper
• Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: The Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study

  2012cites this paper
• Allergic rhinitis and asthma: celebrating 100 years of immunotherapy.

  2011cites this paper
• Une nouvelle impulsion dans le traitement des allergies

  2011cites this paper
• Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness

  2011cites this paper
• Practice parameter Rhinitis 2020: A practice parameter update

  year unknowncites this paper